About Visensia

Visensia is Data-Fusion Software for Early-Detection Patient Monitoring and the only FDA-cleared index for multiple physiological parameter assessment.

Features and Benefits

Quicker Response to Patient Deterioration

• Average 6.3 hours advance warning of critical instability¹
• Average 9.4 minutes earlier warning than single channel alarms²
• 60% reduction in serious instability²

Reduction in Unexpected Deaths

• No unexpected deaths during eight weeks of Visensia monitoring, compared to 6 unexpected deaths in the eight prior weeks²
• In 24 months of Visensia monitoring, no patient had an unexpected fatal cardiac event³

Less Alarm Fatigue

• 79.3% Sensitivity; 80.5% Specificity⁴
• Only 1.6 false alerts per 100 hours of monitoring⁵

Improved Efficiency

• More efficient MET activations
• Improved communication and workflow
• Opportunity to reduce insurance premiums through reduced risk profiles

References:

1. Hravnak et al. Arch Intern Med 2008 Vol 168 (12) 1300-8. Defining the Incidence of Cardiorespiratory Instability in Patients in Step-down Units Using an Electronic Integrated Monitoring System.
2. Hravnak et al. Crit Care Med 2011 Vol 39 (1) 65-72.  Cardiorespiratory instability before and after implementing an integrated monitoring system.
3. Michael R Pinsky MD. Communication on file, OBS Medical Ltd.
4. Woods et al (submitted for publication). Predictive Value of an Automated Neural-Network-Based Early-Warning System for Detecting Early Signs of Physiological Deterioration in Hospitalized Patients.
5. Tarassenko et al, 31st Annual International Conference of the IEEE EMBS, Minneapolis, Minnesota, USA, September 2-6, 2009. Book of abstracts pages 4650-3